Boule Diagnostics
3.90 SEK
-0.26 %
Less than 1K followers
BOUL
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Boule Diagnostics
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 498.9 | 400.5 | 463.3 | 548.1 | 571.3 | 558.5 | 489.6 |
| growth-% | -19.7 % | 15.7 % | 18.3 % | 4.2 % | -2.2 % | -12.3 % | |
| EBITDA | 70.0 | -5.9 | 36.0 | 29.0 | 39.3 | -257.4 | 32.0 |
| EBIT | 70.0 | -5.9 | 36.0 | 29.0 | 39.3 | -257.4 | 22.3 |
| Profit before taxes | 50.6 | -49.0 | 28.8 | 20.8 | 30.1 | -268.5 | 6.1 |
| Net income | 37.5 | -48.0 | 23.3 | 12.7 | 25.0 | -223.3 | -3.5 |
| EPS | 1.37 | -1.75 | 0.85 | 0.46 | 0.64 | -5.75 | -0.10 |
| Dividend | 0.00 | 0.39 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | 0.0 % | -22.2 % | 45.8 % | 0.0 % | 0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 14.0 % | -1.5 % | 7.8 % | 5.3 % | 6.9 % | -46.1 % | 6.5 % |
| EBIT-% | 14.0 % | -1.5 % | 7.8 % | 5.3 % | 6.9 % | -46.1 % | 4.6 % |
| ROE | 11.3 % | -17.8 % | 7.9 % | 2.7 % | 5.3 % | -82.8 % | -2.1 % |
| ROI | 6.4 % | -10.0 % | 4.1 % | 1.7 % | 3.3 % | -37.8 % | -0.7 % |